KRASG12R-突变胰腺癌具有有限的ERK/MAPK转录活动和独特的瘤微环境
Rachel A Burge1, Ozgun Le Roux2, Olesja Popow3
1Medical University of South Carolina Charleston, SC United States.
在胰腺癌中KRASG12R突变显示瘤生长速度较慢,比KRASG12D更好的生存率. 这是由于ERK/MAPK信号减少和不同的瘤微环境,这表明KRASG12R作为预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 与 KRASG12D/V 突变相比,胰腺管道腺癌 (PDAC) 患有 KRASG12R 突变的患者的生存率有所改善.
- 了解这种生存差异背后的分子机制对于开发向疗法至关重要.
研究的目的:
- 调查KRASG12R与KRASG12D/V突变的PDAC患者观察到的差异性结果的机制基础.
- 为了比较与PDAC.中KRASG12R和KRASG12D突变相关的信号通路,转录网络和瘤微环境 (TME).
主要方法:
- 开发一种具有KrasG12R和p53R172H突变的基因工程小鼠模型 (GEMM).
- 在细胞系,GEMM和患者衍生异种移植模型中对KRAS突变选择性转录和信号的比较分析.
- 评估PI3K和ERK/MAPK通路激活,转录输出和TME特征 (原体沉积,肝脏入侵).
主要成果:
- 与KRASG12D模型相比,KRASG12R-GEMMs显示出显著有限的瘤发生和较慢的疾病进展.
- 直接通过KRAS介导的PI3K激活对于GEMM中的瘤启动至关重要,但KRAS不是人类PDAC模型中主要的PI3K驱动因素.
- KRASG12R和KRASG12D激活了类似的转录网络,但KRASG12R显示ERK/MAPK核转位和转录输出减少.
- 人类KRASG12R瘤表现出改变的TME与降低原沉积和减少转移性肝脏入侵.
结论:
- 尽管ERK/MAPK信号传导和转录活动减少,但KRASG12R可以驱动瘤发生.
- 人类的KRASG12D和KRASG12R瘤表现出类似的PI3K活性,但差异性的ERK/MAPK信号和TME影响是关键.
- KRASG12R突变状态可以作为一个有价值的预后生物标志物,用于指导PDAC的治疗策略.
更多相关视频
09:19Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis
Published on: June 22, 2021
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
相关概念视频
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
The Tumor Microenvironment
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Prokaryotic Transcriptional Activators and Repressors
MAPK Signaling Cascades
